Market Overview

UPDATE: Stifel Upgrades Brooks Automation As Life Sciences Are Key To Growth


In a report published Friday, Stifel analyst Patrick Ho upgraded the rating on Brooks Automation (NASDAQ: BRKS) from Hold to Buy, and named a $13.00 price target.

In the report, Stifel noted, “We are upgrading shares of Brooks Automation from a Hold to a Buy rating and establishing a $13 target price, which we believe reflects a sum-of-parts valuation analysis over the next few years. We are now comfortable with the company's growth prospects in its emerging life sciences business and as we have cited previously, we believe the growth in this area will be the key driver in the overall company's fortunes and the appreciation potential in the stock.”

Brooks Automation closed on Thursday at $9.92.

Latest Ratings for BRKS

Nov 2020Stephens & Co.UpgradesEqual-WeightOverweight
Nov 2020Credit SuisseMaintainsNeutral
Nov 2020NeedhamMaintainsBuy

View More Analyst Ratings for BRKS
View the Latest Analyst Ratings


Related Articles (BRKS)

View Comments and Join the Discussion!

Posted-In: Patrick Ho StifelAnalyst Color Upgrades Analyst Ratings

Latest Ratings

DEMorgan StanleyMaintains335.0
SBNYRaymond JamesMaintains138.0
CORTHC Wainwright & Co.Maintains32.0
AHEXYMorgan StanleyDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at